3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow TAK-875 Placebo: new trials by email Literature Review of TAK-875 Placebo trials Research Report on TAK-875 Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes TAK-875, TAK-875 Placebo, Glimepiride - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | Takeda | 33 | 2013-04-01 | 2016-06-01 |
| Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes TAK-875, TAK-875 Placebo - Type 2 Diabetes Mellitus | Phase 3 | Terminated | Takeda | 393 | 2012-10-01 | 2015-11-11 |
| Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease TAK-875, TAK-875 Placebo - Type 2 Diabetes, Cardiovascular Disease | Phase 3 | Terminated | Takeda | 3207 | 2012-06-01 | 2015-10-19 |
Diabetes Mellitus, Type 2 (3) · Cardiovascular Diseases (1)
Takeda (3)
Australia (2) · Bulgaria (2) · Canada (2) · Hungary (2) · New Zealand (2) · Poland (2) · Romania (2) · Slovakia (2) · South Korea (2) · Taiwan (2) · United States (2) · Argentina (1) · Brazil (1) · China (1) · Croatia (1)